ASX - By Stock
|
PCK |
Re:
News: PCK Painchek Announces A$1.59M Underwritten Non-Renounceable Pro-Rata Entitlement Offer
|
|
TheWhale500
|
42 |
16K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
42
|
16K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Investor Update Presentation
|
|
TheWhale500
|
61 |
22K |
3 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
61
|
22K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Investor Update Presentation
|
|
TheWhale500
|
61 |
22K |
8 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
61
|
22K
|
8
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Trading Halt
|
|
TheWhale500
|
45 |
14K |
2 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
45
|
14K
|
2
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Trading Halt
|
|
TheWhale500
|
45 |
14K |
3 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
45
|
14K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Trading Halt
|
|
TheWhale500
|
45 |
14K |
10 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
45
|
14K
|
10
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
20K
|
16M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
1 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
1 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
1
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
20K
|
16M
|
4
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
5 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
20K
|
16M
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
TheWhale500
|
425 |
125K |
10 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
5 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
20K
|
16M
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
1 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
377
|
142K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
3 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
118
|
37K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
118
|
37K
|
2
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Application for quotation of securities - PCK
|
|
TheWhale500
|
16 |
4.7K |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
16
|
4.7K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Application for quotation of securities - PCK
|
|
TheWhale500
|
16 |
4.7K |
3 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
16
|
4.7K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
7 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
20K
|
16M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
1 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
0 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
0 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
1 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
0 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
0 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
0 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
TheWhale500
|
118 |
37K |
1 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
1
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
6 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
20K
|
16M
|
6
|
|
ASX - By Stock
|
FFM |
Re:
Ann: AuTECO Minerals Appoints New Management Team
|
|
TheWhale500
|
24 |
11K |
5 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
24
|
11K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
TheWhale500
|
24K |
12M |
1 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
24K
|
12M
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
0 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
1 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
0 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
0 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
4 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
TheWhale500
|
377 |
142K |
5 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
5
|
|
ASX - By Stock
|
PCK Technology |
Re:
PainChek & Philips Collaboration
|
|
TheWhale500
|
99 |
49K |
14 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
99
|
49K
|
14
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
8 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
20K
|
16M
|
8
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
4 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
20K
|
16M
|
4
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
TheWhale500
|
20K |
16M |
9 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
20K
|
16M
|
9
|
|
ASX - By Stock
|
PCK Technology |
Re:
PainChek & Philips Collaboration
|
|
TheWhale500
|
99 |
49K |
2 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
99
|
49K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
TheWhale500
|
98 |
45K |
3 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
98
|
45K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
TheWhale500
|
98 |
45K |
3 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
98
|
45K
|
3
|
|